On-demand webinar: The EU JCA process: Opportunities and challenges in bringing innovative medicines to patients in Europe
Key webinar learnings:
- The rationale behind the JCA and initial expectations of the framework
- Experience with products that have gone through the pilot phase, providing insight into the workings of the JCA process
- Potential impact anticipated for patient access to innovative health products
- The opportunities and challenges presented by the JCA
Fill out the form below to watch the webinar
The Joint Clinical Assessment (JCA) process is central to the European Union’s Regulation on Health Technology Assessment (HTAR), which seeks to improve patient access to innovative health technologies, including medicines and medical devices. Many factors contribute to access challenges, including the wide variation in how long each country takes to manage the HTA process on a national and sub-national level, lack of healthcare system resources in smaller EU countries, and a tendency by the industry to focus on larger markets in Europe.
During this panel discussion healthcare system experts from AmerisourceBergen, the European Federation of Pharmaceutical Industries and Associations (EFPIA), MSD, PharmaLex, and Vintura, will explore the JCA process and efforts to ensure timely access to innovative healthcare products within this new framework. The discussion will consider the challenges and opportunities presented by the JCA and the potential next steps to best prepare Pharma & Biotech companies to manage the new process.
Speakers:
- Tommy Bramley, Senior Vice President, Market Access & Global Consulting, AmerisourceBergen
- Mihai Rotaru, Senior Manager Market Access, EFPIA (European Federation of Pharmaceutical Industries and Associations)
- Jurgen Huismans, Global Director Access & HTA Strategy, MSD
- Herbert Altmann, Head Commercialization and Access Solutions Europe, PharmaLex
- Casper Paardekooper, Partner, Vintura
Cencora.com is providing automated translations to assist in reading the website in languages other than English. For these translations, reasonable efforts have been made to provide an accurate translation, however, no automated translation is perfect nor is it intended to replace human translators. These translations are provided as a service to users of Cencora.com and are provided "as is." No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, or correctness of any of these translations made from English into any other language. Some content (such as images, videos, Flash, etc.) may not be accurately translated due to the limitations of the translation software.
Any discrepancies or differences created in translating this content from English into another language are not binding and have no legal effect for compliance, enforcement, or any other purpose. If any errors are identified, please contact us. If any questions arise related to the accuracy of the information contained in these translations, please refer to the English version of the page.